… For some time the medical treatment of glaucoma has consisted of topical β-blockers, …
However, the therapeutic arsenal available for the medical treatment of glaucoma has recently …

… blockers, betaxolol and timolol, whether the amount of IOP reduction is truly a good surrogate
for successful glaucoma therapy … for successful treatment in glaucoma not only the amount …

… the therapeutic benefits of these drugs ; as seen with the use of diuretics and β-blockers in
… effect of ocular β-blockers may influence the choice of the glaucoma therapy, especially in …

… The most important factor affecting the success of glaucoma therapy is compliance. Using
more than two medications would be difficult to manage even for young patients, let alone …

… Memantine, an N-methyl-D-aspartate receptor blocker currently approved for dementia, is
the neuroprotectant farthest along in the process seeking regulatory approval for glaucoma …

… in the progression of glaucoma. but the impact of long-term beta blocker therapy on ocular
… glaucoma (POAG) before and during long-term treatment with a nonselective topical beta …

… topical β-blocker therapy. The purpose of this review is to discuss the clinical adverse events
… with topical β-blockers and to provide information regarding newer glaucoma products and …

… Glaucomatous individuals are often elderly and may be … and treated with systemic beta-blocker
therapy. The efficacy of topical … in glaucoma patients on concurrent systemic beta-blocker …

… In this review, I discuss current and emerging medical therapies for glaucoma and their …
rapidly developed as a therapeutic agent for glaucoma. The β-blockers are known as aqueous …

… be a more appropriate first-line therapy for ocular hypertension and glaucoma patients
concurrently taking systemic β-blockers. Current glaucoma therapy is based on the lowering of …